05-23-3831 Sigma-AldrichBQ-123, Sodium Salt - CAS - Calbiochem
A highly potent, selective, and competitive ETA (endothelin) receptor antagonist (Ki = 40 nM for ETA versus Ki = 2.5 µM for ETB).
More>> A highly potent, selective, and competitive ETA (endothelin) receptor antagonist (Ki = 40 nM for ETA versus Ki = 2.5 µM for ETB). Less<<BQ-123, Sodium Salt - CAS - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Recommended Products
概述
| Replacement Information |
|---|
重要规格表
| Empirical Formula |
|---|
| C₃₁H₄₁N₆O₇ · Na |
价格及供货情况
| 产品目录编号 | 库存情况 | 包装 | 数量 / 包装 | 价格 | 数量 | |
|---|---|---|---|---|---|---|
| 05-23-3831-1MGCN |
|
塑胶安瓿;塑胶针药瓶 | 1 mg |
|
— |
| Product Information | |
|---|---|
| ATP Competitive | N |
| Form | White solid |
| Formulation | Supplied as a sodium salt. Sold on the basis of peptide content. |
| Hill Formula | C₃₁H₄₁N₆O₇ · Na |
| Chemical formula | C₃₁H₄₁N₆O₇ · Na |
| Hygroscopic | Hygroscopic |
| Reversible | N |
| Sold on the basis of peptide content | Y |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | ETA (endothelin) receptor antagonist |
| Primary Target K<sub>i</sub> | 40 nM for ETA versus 2.5 µM for ETB |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Peptide Content | Y |
| Peptide Sequence | Cyclo(D-Asp-Pro-D-Val-Leu-D-Trp, Na) |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 产品目录编号 | GTIN |
| 05-23-3831-1MGCN | 04055977226812 |
Documentation
BQ-123, Sodium Salt - CAS - Calbiochem MSDS
| 职位 |
|---|
BQ-123, Sodium Salt - CAS - Calbiochem 分析证书
| 标题 | 批号 |
|---|---|
| 05-23-3831 |
参考
| 参考信息概述 |
|---|
| Nambi, P., et al. 1996. J. Pharmacol. Exp. Ther. 277, 1567. Bax, W.A., and Saxena, P.R. 1994. Trends Pharmacol. Sci. 15, 379. Ihara, M., et al. 1991. Biochem. Biophys. Res. Commun. 178, 132. |